Pamela Wapnick
Chief Financial Officer · Metagenomi Therapeutics, Inc.
- 2024
- Sep 10, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pamela Wapnick files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Laurence Reid - $23K in MGX purchases and sales in the last 12 months
- Jian Irish - $16K in MGX purchases and sales in the last 12 months
- Brian C. Thomas - $12K in MGX purchases and sales in the last 12 months
- Matthew Wein - $3K in MGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pamela Wapnick?
Pamela Wapnick is a corporate insider, tracked as Chief Financial Officer of Metagenomi Therapeutics, Inc. (MGX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pamela Wapnick submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Pamela Wapnick been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($17K) across all tracked filings.
